Caplin Point attends TRINITY INDIA 2026 on May 28
Caplin Point Laboratories Limited announced its participation in the 16th Annual Global Investor Conference TRINITY INDIA 2026 on May 28, 2026, in Mumbai. The company will engage with analysts and institutional investors through one-on-one and group meetings starting at 10.00 AM. The schedule is subject to change based on exigencies.

*this image is generated using AI for illustrative purposes only.
Caplin Point Laboratories Limited has announced its participation in the 16th Annual Global Investor Conference titled TRINITY INDIA 2026. The event is scheduled to take place on May 28, 2026, in Mumbai. The company will engage with various analysts and institutional investors during the conference.
The interaction will include both one-on-one and group meetings on a physical basis. The meeting is set to commence at 10.00 AM. The schedule is subject to changes based on exigencies concerning the analysts, institutional investors, or the company.
Meeting Details
| Date, Time & Location | Participant | Interaction Type | Meeting Type |
|---|---|---|---|
| May 28, 2026, Thursday, 10.00 AM at Mumbai | Various Analyst/Institutional Investors | One to one basis and Group Meeting | Physical |
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Venkatram G, General Counsel & Company Secretary of Caplin Point Laboratories Limited.
Historical Stock Returns for Caplin Point Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.46% | +3.96% | +18.57% | +8.29% | -9.20% | +234.77% |
What strategic updates or pipeline developments might Caplin Point Laboratories reveal to institutional investors at the TRINITY INDIA 2026 conference?
How could increased institutional investor interest following the conference impact Caplin Point Laboratories' stock liquidity and valuation multiples?
What expansion plans in emerging markets or new therapeutic segments is Caplin Point likely to highlight to attract fresh institutional capital?


































